IVBXF
INNOVENT BIOLOGICS INCstockOTC
EODOct 2, 2026
12.80USD+2.334%(+0.29)396
Loading…
Loading…
20.85B
Healthcare
Biotechnology
HQ
Suzhou, Jiangsu, China
5,294
Previous Close
$12.51
Beta
0.21
52-Week High
$15.01 2026-08-28
52-Week Low
$9.10 2026-06-09
SMA 50
$12.24
SMA 200
$11.40
Avg. Vol 10D
1,286
Avg. Vol 30D
2,315
Avg. Vol 90D
4,960
Relative Vol
0.17
1.63B
1.61B
1,032,783
0.06%
252.45
Sep 29, 2026
Sep 28, 2026
Innovent expands Phase III MarsLight-11 trial to non-squamous NSCLC ·
Clinical Trials Arena
Sep 27, 2026
IVBXF Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 13.36 | 2026-09-28 | -4.18% | 8.694 |
| 1M | 13.11 | 2026-09-04 | -2.35% | -3.553 |
| 3M | 11.68 | 2026-07-06 | +9.64% | -0.664 |
| 6M | 11.89 | 2026-04-06 | +7.67% | 0.362 |
| 1Y | 12.72 | 2025-10-03 | +0.65% | 0.206 |
| 2Y | 6.00 | 2024-10-03 | +113.37% | — |
| 5Y | 9.50 | 2021-10-04 | +34.76% | 0.095 |
IVBXF Stock Summary
INNOVENT BIOLOGICS INC (OTC:IVBXF) stock price today is $12.80, and today's volume is 396. IVBXF is up 2.334% today. The 30 day average volume is 2,315. IVBXF market cap is $20.85B with 1.63B shares outstanding.